Chong-xian Pan, MD, PhD
Dr. Pan is Associate Professor of Medicine and Urology, a board-certified medical oncologist and a physician-scientist specializing in bladder cancercare and research at the University of California, Davis. He earned his medical degree at Fudan University Shanghai Medical College, Shanghai, China, a PhD in Microbiology and Immunology at Loyola University of Chicago and an MS in Clinical Research at the University of California Davis. His post-graduate training included a four-year residency of Urology in China, residency of Internal Medicine at Saint Francis hospital, and a fellowship of Hematology and Medical Oncology at Indiana University.
Dr. Pan leads a multi-faceted bladder cancer research program at UC Davis. His lab focuses on translational research in bladder cancer, such as development of bladder cancer-specific nanotheranostics for the diagnosis and treatment of bladder cancer, microdosing approaches to identify chemoresistance and the underlying chemoresistance mechanisms for personalized chemotherapy, bladder cancer mouse xenograft models to develop targeted therapy and precision medicine, and cancer stem cells. He is an inventor on three patents, with two of those projects reaching the clinical trial stage. In addition to translating his own preclinical studies into human studies, he serves the PI of several other clinical trials. Dr. Pan has received numerous awards including the NCI Cancer Clinical Investigator Team Leadership Award. His research has been funded by the Veteran Administration Merit Award, NIH, DoD, American Cancer Society, California Institute for Regenerative Medicine and others.